Figure 1From: Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancerExpression of E-cadherin, β-catenin and WNT-1 in ovarian cancer. E-cadherin displayed strong membranous and cytoplasmic immunoreactivity in cancer cells Strong membranous, moderate cytoplasmic and lack of nuclear expression of β-catenin was observed in tumour tissue. In ovarian carcinoma, there was strong WNT-1 immunoreactivity.Back to article page